Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2014-06-29 Proxy Solicitation & In…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Form of Proxy for use at the Extraordinary General Meeting to be held on July 16, 2014
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use at an Extraordinary General Meeting (EGM) of PW Medtech Group Limited. It includes instructions for shareholders to appoint a proxy to vote on their behalf at the meeting, details about the resolution to be voted on, and procedural notes about the proxy form. There is no financial data, no report content, no management discussion, or earnings information. It is clearly a meeting-related document facilitating shareholder voting rather than a report or announcement of results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings.
2014-06-29 English
NOTICE OF AN EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is titled 'NOTICE OF AN EXTRAORDINARY GENERAL MEETING' and details the time, place, and agenda of the EGM, including a resolution to approve an Equity Transfer Agreement. It includes procedural notes about proxy voting and meeting conduct. There is no financial data, report content, or detailed analysis present. The document is an announcement of a meeting rather than a report or detailed filing. Given the nature and length (under 5,000 characters), this fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about a shareholder meeting and related resolutions, not a full report or proxy solicitation material.
2014-06-29 English
MAJOR TRANSACTION - ACQUISITION OF MEDICAL DEVICE COMPANY IN THE PRC
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by PW Medtech Group Limited regarding a major transaction, specifically the acquisition of a medical device company in the PRC. It includes detailed information such as a letter from the board, financial information of the group, accountant's report of the target group, unaudited pro forma financial information of the enlarged group, and a notice of an extraordinary general meeting (EGM) to approve the acquisition. The document is comprehensive and includes financial data, transaction details, and meeting notices. This type of document is typical of a Proxy Solicitation & Information Statement (PSI), which provides shareholders with information to make informed voting decisions at a meeting, especially for major transactions requiring shareholder approval. It is not merely an announcement or a brief notice, but a detailed circular with appendices and financial reports related to the transaction. Therefore, the appropriate classification is Proxy Solicitation & Information Statement (PSI).
2014-06-29 English
NEXT DAY DISCLOSURE RETURN - CHANGE IN ISSUED SHARE CAPITAL
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to share option exercises and share repurchases, with dates and prices. The document references compliance with Listing Rules of the Hong Kong Stock Exchange and provides detailed tables of share capital changes and repurchase information. This type of document is a regulatory disclosure about capital changes and share buybacks, not a full financial report or earnings release. It fits the category of Share Issue/Capital Change announcements, as it reports on new share issues and repurchases, consistent with the SHA category definition.
2014-06-18 English
MAJOR TRANSACTION ACQUISITION OF MEDICAL DEVICE COMPANY IN THE PRC DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from PW Medtech Group Limited regarding a delay in the dispatch of a circular related to a major transaction (acquisition of a medical device company). It references a previous announcement and states that the circular containing notice of an Extraordinary General Meeting (EGM) and further information will be delayed. The document is short (1869 characters) and serves as a notification about the timing of a report (the circular), not the report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement about the delay, rather than the actual circular or transaction documents.
2014-06-11 English
NEXT DAY DISCLOSURE RETURN - CHANGE IN ISSUED SHARE CAPITAL
Share Issue/Capital Change Classification · 95% confidence The document is a Next Day Disclosure Return for a Main Board listed issuer, PW Medtech Group Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues pursuant to the exercise of share options and confirms compliance with Listing Rules regarding share repurchases. The content focuses on reporting changes in share capital and share buybacks, which aligns with announcements related to share capital changes rather than a full financial report or earnings release. The document is regulatory in nature, providing detailed disclosure of share capital changes as required by the stock exchange rules. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2014-06-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.